{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-072467","form_type":"8-K","ticker":"PYXS","cik":"0001782223","company_name":"Pyxis Oncology, Inc.","filed_at":"2024-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.070819+00:00","generated_at":"2026-06-01T04:52:39.303860+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Pyxis Oncology stockholders elect four directors, ratify Ernst & Young as auditor","bullets":["Dr. Santhosh Palani elected Class I director with 28,241,400 for, 93,674 withheld.","Class III directors elected: John Flavin (21,045,395 for), Lara Sullivan (24,369,861), Jakob Dupont (28,220,452).","Ratification of Ernst & Young as FY2024 auditor passed with 42,153,375 for, 151,087 against, 31,729 abstain.","Quorum of 42,336,191 shares present from 58,876,390 outstanding as of record date April 18, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-072467","json":"https://secwatch.observer/filing/0000950170-24-072467.json","markdown":"https://secwatch.observer/filing/0000950170-24-072467.md","text":"https://secwatch.observer/filing/0000950170-24-072467.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782223/000095017024072467/0000950170-24-072467-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782223/000095017024072467/pyxs-20240611.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:52:39.303860+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}